Molly S Shoichet

This inventor holds 28 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Hydrogel Technology. Top assignees: Cytotherapeutics, Inc., University of Toronto, Bonetec Corporation. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Molly S Shoichet. Retrieved from https://idiyas.com/inventor/molly-s-shoichet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 3)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.6

ph-index = 18

Forward Citations = 1,216(Granted Patents)

Location History:

Canton, MA (US) (1999)
Canton, CA (US) (2001)
Toronto, CA (1998 - 2022)

Company Filing History:

9 out of 32

Cytotherapeutics, Inc.

patents

5 out of 529

University of Toronto

6. 8 out of 834,453

Other

patents

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Hydrogel Composition

Drug Delivery

Cell Encapsulation

Biomolecule Immobilization

Therapeutic Agents

Polymer Scaffold

Tissue Engineering

Controlled Release

Temperature Sensitive Polymers

Bioartificial Organs

Fluoropolymers

Macroporous Structures

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12419878 - Sustained release local anesthetic hydrogel composition (2025-09-23),

2. 12343916 - Anti-adhesive hydrogel composition (2025-07-01),

3. 11213490 - Encapsulation-free controlled protein release system (2022-01-04),

4. 9290617 - Method of biomolecule immobilization on polymers using click-type chemistry (2016-03-22),

5. 9205047 - Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix (2015-12-08),

6. 9205046 - Enhanced stability of inverse thermal gelling composite hydrogels (2015-12-08),

7. 8980248 - Injectable polymer composition for use as a cell delivery vehicle (2015-03-17),

8. 8629197 - Chemically patterned hydrogels, manufacture and use thereof (2014-01-14),

9. 7767656 - Blends of temperature sensitive and anionic polymers for drug delivery (2010-08-03),

10. 7022522 - Macroporous polymer scaffold containing calcium phosphate particles (2006-04-04),

11. 6969480 - Method of producing structures using centrifugal forces (2005-11-29),

12. 6875442 - Process for growing tissue in a biocompatible macroporous polymer scaffold and products therefrom (2005-04-05),

13. 6787090 - Method of producing structures using centrifugal forces (2004-09-07),

14. 6730762 - Linear copolymers of fluorocarbon-hydrocarbon monomers synthesized in carbon dioxide (2004-05-04),

15. 6544208 - Implantable shunt device (2003-04-08),

Title: Innovations and Contributions of Molly S. Shoichet in Biomaterials

Introduction

Molly S. Shoichet is a prominent figure in the field of biomaterials, based in Toronto, Canada. With an impressive portfolio of 22 patents, she has made significant strides in the development of innovative drug delivery systems and biomolecular interactions.

Latest Patents

Among her latest patents is the "Encapsulation-free controlled protein release system," which introduces a method for controlled protein release without the need for encapsulation. This system enables identical, burst-free extended release profiles for various protein therapeutics, demonstrating the potential to enhance the delivery of therapeutic biomolecules significantly. The technology employs short-range electrostatic interactions for controlled release and has shown effectiveness in vivo, particularly with the delivery of Brain-Derived Neurotrophic Factor (BDNF) in a rat model of stroke.

Another notable invention is the "Method of biomolecule immobilization on polymers using click-type chemistry." This method allows for the covalent immobilization of biomolecules on polymers, streamlining the process of delivering these biomolecules. Utilizing novel synthetic biodegradable polymers, such as a furan/alkyne-functionalized poly(trimethylene carbonate) (PTMC)-based polymer, this technology stands out for its simplicity and efficiency, facilitating intravenous therapeutic delivery.

Career Highlights

Molly S. Shoichet's career includes remarkable contributions to the realm of biomaterials. Her association with companies like Cytotherapeutics, Inc. exemplifies her commitment to advancing therapeutic delivery systems. Through her innovations, she has positioned herself as a leading inventor in her field.

Collaborations

Throughout her illustrious career, Molly has collaborated with esteemed individuals such as Frank T. Gentile and Malcolm Schinstine. These partnerships have enriched her research endeavors and expanded the scope of her innovations in biomaterials.

Conclusion

Molly S. Shoichet's contributions to the field of biomaterials through her inventions and patents have opened new avenues for effective drug delivery systems. Her innovative approaches continue to inspire researchers and hold promise for future therapeutic advancements, making her a distinguished inventor in the biomedical landscape.

Profile summary based on public USPTO records.